These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 23736774)
1. Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA. McCaskill J; Singhania R; Burgess M; Allavena R; Wu S; Blumenthal A; McMillan NA Mol Ther Nucleic Acids; 2013 Jun; 2(6):e96. PubMed ID: 23736774 [TBL] [Abstract][Full Text] [Related]
2. Liposomal siRNA Delivery in Papillary Thyroid Carcinoma Cells. Islam F; Zhou Y; Lam AK Methods Mol Biol; 2022; 2534():121-133. PubMed ID: 35670972 [TBL] [Abstract][Full Text] [Related]
3. Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages. Nogueira E; Freitas J; Loureiro A; Nogueira P; Gomes AC; Preto A; Carmo AM; Moreira A; Cavaco-Paulo A Colloids Surf B Biointerfaces; 2017 Jul; 155():459-465. PubMed ID: 28472749 [TBL] [Abstract][Full Text] [Related]
4. Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes. Hattori Y; Saito H; Oku T; Ozaki KI Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165169 [TBL] [Abstract][Full Text] [Related]
6. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations. Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971 [TBL] [Abstract][Full Text] [Related]
7. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug. Garbuzenko OB; Saad M; Betigeri S; Zhang M; Vetcher AA; Soldatenkov VA; Reimer DC; Pozharov VP; Minko T Pharm Res; 2009 Feb; 26(2):382-94. PubMed ID: 18958402 [TBL] [Abstract][Full Text] [Related]
8. An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: Proof-of-concept in the treatment of psoriasis. Desmet E; Bracke S; Forier K; Taevernier L; Stuart MC; De Spiegeleer B; Raemdonck K; Van Gele M; Lambert J Int J Pharm; 2016 Mar; 500(1-2):268-74. PubMed ID: 26806466 [TBL] [Abstract][Full Text] [Related]
9. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588 [TBL] [Abstract][Full Text] [Related]
10. Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system. Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Harashima H Mol Ther; 2013 Jun; 21(6):1195-203. PubMed ID: 23568259 [TBL] [Abstract][Full Text] [Related]
11. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex. Hattori Y; Nakamura M; Takeuchi N; Tamaki K; Shimizu S; Yoshiike Y; Taguchi M; Ohno H; Ozaki KI; Onishi H J Drug Target; 2019 Feb; 27(2):217-227. PubMed ID: 30024300 [TBL] [Abstract][Full Text] [Related]
12. Long-term silencing of intersectin-1s in mouse lungs by repeated delivery of a specific siRNA via cationic liposomes. Evaluation of knockdown effects by electron microscopy. Bardita C; Predescu D; Predescu S J Vis Exp; 2013 Jun; (76):. PubMed ID: 23851900 [TBL] [Abstract][Full Text] [Related]
13. A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo. Ewe A; Przybylski S; Burkhardt J; Janke A; Appelhans D; Aigner A J Control Release; 2016 May; 230():13-25. PubMed ID: 27061141 [TBL] [Abstract][Full Text] [Related]
14. Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy. De Backer L; Cerrada A; Pérez-Gil J; De Smedt SC; Raemdonck K J Control Release; 2015 Dec; 220(Pt B):642-50. PubMed ID: 26363301 [TBL] [Abstract][Full Text] [Related]
15. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes. Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847 [TBL] [Abstract][Full Text] [Related]
16. Peptide and nucleic acid-directed self-assembly of cationic nanovehicles through giant unilamellar vesicle modification: Targetable nanocomplexes for in vivo nucleic acid delivery. Tagalakis AD; Maeshima R; Yu-Wai-Man C; Meng J; Syed F; Wu LP; Aldossary AM; McCarthy D; Moghimi SM; Hart SL Acta Biomater; 2017 Mar; 51():351-362. PubMed ID: 28110069 [TBL] [Abstract][Full Text] [Related]
17. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing. Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968 [TBL] [Abstract][Full Text] [Related]
18. Lipopeptide Delivery of siRNA to the Central Nervous System. Zabel MD; Mollnow L; Bender H Methods Mol Biol; 2019; 1943():389-403. PubMed ID: 30838631 [TBL] [Abstract][Full Text] [Related]
19. Intracellular Delivery of Short Interfering RNA in Rat Organ of Corti Using a Cell-penetrating Peptide PepFect6. Dash-Wagh S; Jacob S; Lindberg S; Fridberger A; Langel U; Ulfendahl M Mol Ther Nucleic Acids; 2012 Dec; 1(12):e61. PubMed ID: 23232329 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic Effects of WT1 Silencing via Respiratory Administration of Neutral DOPC Liposomal-siRNA in a Lung Metastasis Melanoma Murine Model. Ramos-Gonzalez MR; Vazquez-Garza E; Garcia-Rivas G; Rodriguez-Aguayo C; Chavez-Reyes A Noncoding RNA; 2023 Mar; 9(2):. PubMed ID: 36960966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]